ZANUS AI FOR PHARMA & BIOTECH — SITE OUTREACH

Every site informed. Nothing sent unreviewed.

Site newsletters, enrollment-status updates, document-expiry reminders, investigator-meeting logistics — drafted by the AI from your own study records, in each site’s language, and queued for your approval. Study communications discipline without a communications hire.

Get started

Private tenant or your own server · unlimited users · GxP-conscious architecture

AI marketing module drafting study and site communications

Campaigns and sequences drafted from study records — site updates, reminders, newsletters — awaiting approval.

What it does

Audiences from your own records

Sites behind on enrollment, coordinators with expiring documents, investigators due a quarterly update: audiences built from your study data — no exporting lists to a mailing tool.

Sequenced, not spammed

A document-expiry reminder, a follow-up a week later, an escalation to the CRA if unanswered: sequences drafted for approval, stopped automatically when the site responds.

40 languages, one voice

A site in Warsaw and a site in Osaka get the same update in their own language, in your program’s voice — with your regulatory-review rules applied first.

From the study record to the outbox, without export

Audience, content and sending live in the same system as the study records — nothing leaves your tenant to reach a mailing platform. “Remind every site with a delegation-log gap” becomes a drafted, scheduled sequence in minutes.

Audiences from your own study data — private by architecture
Sequences drafted for review, never auto-sent by default
Responses tracked back to the site record

AI-drafted site communications from study records

Site communications awaiting sponsor approval

Approval first, always

Every outbound study communication waits in the approval queue unless your team designates the category as auto-send. In a regulated program, that gate is not bureaucracy — it is the point.

Approval workflow per communication type
Full history of what was sent to which site
Opt-outs and contact preferences enforced by the system

Life-science software is sold per validated seat and per module — a LIMS here, an eTMF there, a QMS somewhere else — while regulatory affairs still re-types the same deviation data into three systems and the literature pile grows over the weekend. Zanus AI: one AI operating system across the trial, the lab and the submission — unlimited users, GxP-conscious by architecture, hosted in your private tenant or air-gapped inside your facility.

Questions, answered

Can promotional-style content go through medical-legal review first?

Yes — the approval queue is the mechanism: route categories to the reviewers you designate, and nothing in that category sends until they approve. The audit record keeps every version.

Does it handle BD and partner outreach too?

Yes — the same module drafts partner sequences and conference follow-ups from your CRM records, with the same approval-first discipline.

Every site informed. Nothing sent unreviewed.

What it does

From the study record to the outbox, without export

Approval first, always

Questions, answered

See it working on YOUR lab — the demo IS the product.